Aperio Group, LLC - AIMMUNE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.

Links
Filings
External links
Quarter-by-quarter ownership
Aperio Group, LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$313,000
+2.6%
9,089
-0.4%
0.00%0.0%
Q4 2019$305,000
+301.3%
9,124
+149.2%
0.00%–
Q2 2019$76,000–3,662–0.00%–
 Download
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q3 2020.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders